These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37892204)

  • 1. The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.
    Hardy MP; Mansour M; Rowe T; Wymann S
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into complement pathway inhibition by CR1 domain duplication.
    Wymann S; Nair AG; Ewert S; Powers GA; Wan SS; Pelzing M; Baz Morelli A; Rowe T; Hardy MP
    J Biol Chem; 2024 Jul; 300(7):107451. PubMed ID: 38844131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
    Wymann S; Mischnik M; Leong D; Ghosh S; Tan X; Cao H; Kuehnemuth B; Powers GA; Halder P; de Souza MJ; James HS; Tomasetig V; Lind H; Rossato P; Owczarek CM; Ow SY; Dower SK; Baz Morelli A; Rowe T; Hardy MP
    Biochem J; 2022 May; 479(9):1007-1030. PubMed ID: 35470373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
    Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
    J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.
    Wymann S; Dai Y; Nair AG; Cao H; Powers GA; Schnell A; Martin-Roussety G; Leong D; Simmonds J; Lieu KG; de Souza MJ; Mischnik M; Taylor S; Ow SY; Spycher M; Butcher RE; Pearse M; Zuercher AW; Baz Morelli A; Panousis C; Wilson MJ; Rowe T; Hardy MP
    J Biol Chem; 2021; 296():100200. PubMed ID: 33334893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
    J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
    Klickstein LB; Barbashov SF; Liu T; Jack RM; Nicholson-Weller A
    Immunity; 1997 Sep; 7(3):345-55. PubMed ID: 9324355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
    Mossakowska D; Dodd I; Pindar W; Smith RA
    Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of CR1 complement receptor in pathology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function relationships of complement receptor type 1.
    Krych-Goldberg M; Atkinson JP
    Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
    Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
    J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor is an inhibitor of the complement cascade.
    Iida K; Nussenzweig V
    J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.